(SP) Página en construcción. Gracias por tu visita (EN) Page under construction. Thank you for your visit
Oct. 21, 2026
Dr. Christian Chapa González was invited to participate in the College Fair organized by Instituto México, part of the Marist educational network, where he delivered a talk entitled “Science from Ciudad Juárez: Discoveries for the World.”
During his presentation, Dr. Chapa shared his personal journey into science, reflecting on how he chose his academic path—or, as he humorously explained, how science ultimately chose him. He also challenged traditional stereotypes of what scientists look like, encouraging high school students to recognize that scientific careers are closer and more accessible than they might imagine.
A central part of the talk highlighted the achievements of students from the Nanomedicine Research Group at UACJ, presenting examples of their research projects, scientific publications, and international contributions. Dr. Chapa emphasized that the students currently conducting research and publishing their findings in international congress or scientific journals were themselves high school students just a few years ago. Their experiences demonstrate how curiosity, dedication, and opportunities in scientific research can transform young students into contributors to the global scientific community.
The event also featured Diego Carrillo, an Instituto México alumnus and former member of the Nanomedicine Research Group, who shared his firsthand experience of participating in scientific research during his university education. His involvement was particularly meaningful, as his review article, “Comparative Analysis of Metal–Organic Frameworks (MOFs) and Polymeric (PLGA) Nanocarriers for Anticancer Drug Encapsulation and pH-Dependent Release,” was recently accepted for publication in Current Drug Delivery, an international scientific journal published by Bentham Science.
Diego spoke to the students about his experience as part of the research group and the significance of seeing his scientific work accepted for publication in an international journal. As a graduate of the very institution hosting the event, his story provided a tangible example of how students from Instituto México can pursue scientific careers and make meaningful contributions to research.
Oct. 19, 2026
Dr. Christian Chapa González has authored an invited Perspective for Nano Futures, an IOP Publishing journal, proposing design principles for nanomedicines intended for leukemia and other blood cancers.
Perspectives represent authoritative discussions regarding the future direction of a timely research area. The article, titled “Nanomedicine Without the EPR Effect: Design Principles for Leukemia and Other Hematological Malignancies,” examines how drug delivery systems can be engineered around the biological characteristics of these diseases.
Its central argument is that nanomedicine for blood cancers requires design strategies tailored to malignant cells circulating in the bloodstream and residing in bone marrow. The Perspective identifies priorities including selective cellular targeting, intracellular delivery of therapeutic cargo, and preservation of healthy blood-forming cells.
A Perspective offers a critical assessment of a scientific field and proposes directions for future research. This contribution is an academic outcome of the SECIHTI-funded project CF-2023-G-961 and draws on the research agenda developed by the Nanomedicine Research Group at UACJ.
📃Read the article on IOPscience
Oct.19, 2026
Dr. Christian Chapa González serves on the Scientific and Advisory Board of the AKAP International Congress of Medicine and Health Sciences in Ankara, Türkiye. His participation brings Mexican representation to an international academic forum focused on medicine, health sciences, and interdisciplinary exchange.
Dr. Chapa is the only member of the Scientific and Advisory Board listed with an institutional affiliation in Mexico. The board comprises 58 members, including researchers from Türkiye, the United States, Japan, Australia, Germany, Austria, Spain, Italy, Brazil, and several other countries. This international composition places UACJ within a geographically diverse academic network.
The directory includes academics affiliated with institutions such as the University of Tokyo, New York University, the University of New South Wales, the University of Vienna, and the University of São Paulo. Their presence illustrates the range of institutional backgrounds represented on the board, alongside the contribution of UACJ from Mexico’s northern border region.
Organized by the International Academic Platform (AKAP), the congress aims to bring together academics, researchers, physicians, and health professionals to share scientific findings and encourage collaboration. Its scope encompasses basic and clinical medicine, dentistry, pharmacy, nursing, nutrition, public health, rehabilitation, health technologies, and health management. This breadth provides a setting for dialogue among disciplines that approach human health from different perspectives.
For UACJ, participation in an international scientific and advisory board provides visibility beyond national boundaries. It places the university’s name within a forum where institutions from different educational and research systems are represented, while highlighting the participation of researchers working in Ciudad Juárez in the wider scientific community.
Oct.15, 2026
Dr. Jazmín Cristina Stevens Barrón and Dr. Christian Chapa González received recognition during UACJ’s ceremony honoring excellence in science and technology, held on October 15, 2026, at the Gracia Pasquel Theater. The event celebrated the contributions of members of Mexico’s National System of Researchers (SNII), inventors, and institutional scientific journals.
A distinguished guest was Dr. Liza Elena Aceves López, Director General of Scholarships and Support for the Scientific and Humanities Community at Mexico’s Secretariat of Science, Humanities, Technology and Innovation (SECIHTI). In her remarks, she recognized UACJ’s achievements and emphasized the importance of advancing science, technology, and the humanities through strong connections with society. Her participation highlighted the university’s contribution to Mexico’s scientific community.
These recognitions celebrate the work of our group’s researchers and reaffirm our commitment to scientific inquiry, student training, and research that serves society.
🔗 More info: Excelencia científica y tecnológica desde la frontera
Oct. 14, 2026
Jesús Navarro and Rosa Valeria Delgado represented our group at the 12th International Meeting of Young Researchers in the State of Chihuahua, held on October 13–14, 2026, at UACJ’s University Cultural Center in Ciudad Juárez. The event brought together students and recent graduates to share their research and strengthen their academic training.
Jesús Navarro participated in the Engineering category with the project “Co-encapsulation of Gallic Acid and Vincristine in Cholesterol-Modified Soy Phospholipid Liposomes.”
Rosa Valeria Delgado participated in the Medicine and Health Sciences category with the project “Soy Phospholipid-Based Nanocarriers for the Co-encapsulation of Vincristine and Ellagic Acid: Preliminary Evaluation of Colloidal Stability.”
Their presentations shared our group’s ongoing research on phospholipid-based nanocarriers and provided an opportunity to exchange ideas with fellow researchers. Their participation reflects our commitment to supporting young scientists and developing their skills in research and scientific communication.
🔗 More info: Jovenes Investigadores
Oct. 15, 2026
Dr. Christian Chapa González participated in UACJ’s “Conoce tu Universidad” 2026-2 to showcase activities of the Biomedical Engineering program and introduce high school students to this field. Held October 14–16, 2026, at the University Sports Complex (CEDU), the event brought prospective students closer to the university’s academic programs, research, and services.
This participation offered an opportunity to highlight the connections between engineering, technology, and healthcare while helping students explore their academic interests and future career paths. Through outreach activities like this, our group contributes to UACJ’s efforts to inspire the next generation of university students.
🔗 More info: Conoce tu Universidad 2026-2
Sep. 24, 2026
The Nanomedicine-UACJ Research Group brings together its scientific achievements and the stories of its students in “15 Years of Small Systems… and Big Stories,” a retrospective presentation prepared by Dr. Christian Chapa González at Universidad Autónoma de Ciudad Juárez (UACJ).
Founded in 2012, the group has developed research at the intersection of materials science, chemistry, biology, and biomedical engineering. Its projects have addressed magnetic and gold nanoparticles, biosensors, biomaterials for tissue regeneration, and controlled delivery systems. Across these areas, researchers and students investigate how material properties influence interactions with biomolecules and cells.
Recent projects focus on delivery systems for natural bioactive compounds, including extracts obtained from pecan nuts. This work examines encapsulation, formulation stability, and release behavior, alongside the co-delivery of chemotherapy agents and natural compounds for potential applications in leukemia research.
June 24, 2026
Our research group is pleased to announce the publication of the article “Ternary co-encapsulation in electrospun PVA fibers: release kinetics and mechanisms” in Therapeutic Delivery.
The study reports the development and evaluation of an electrospun poly(vinyl alcohol) nanofiber platform designed for the simultaneous incorporation and controlled release of three bioactive agents: Aloe vera extract, methylglyoxal, and collagen.
This publication reflects the value of interdisciplinary collaboration and the application of materials science, pharmaceutical technology, microbiology, and cell-based evaluation to the development of innovative systems for advanced wound care.
Article: Ternary co-encapsulation in electrospun PVA fibers: release kinetics and mechanisms
Journal: Therapeutic Delivery
Volume and issue: Volume 17, Issue 6, 2026
Published online: June 24, 2026
DOI: https://doi.org/10.1080/20415990.2026.2692882
March 03, 2026
Christian Chapa González has been recognized by IOP Publishing with the Outstanding Reviewer Awards 2025 for his peer-review contributions to the journal Biomedical Materials.
According to IOP Publishing, this distinction is awarded based on the quality, quantity, and timeliness of the reviews completed. The recognition highlights the importance of peer review as a central component of scholarly communication and reflects a strong commitment to scientific integrity and editorial excellence.
This achievement adds to the academic visibility of the research group and reinforces its participation in the international scientific community.
April 7, 2026
We are proud to announce that the director of our Nanomedicine Research Group, Dr. Christian Chapa Gonzalez, has been appointed as the Editor for the upcoming collection: "Advanced Controlled Delivery Systems for Natural Products: Design, Characterization, and Efficacy" in the journal Discover Molecules, published by Springer Nature.
This collection focuses on the latest advancements in encapsulation and delivery platforms for bioactive compounds, highlighting the intersection of molecular science, nanomedicine, and translational health applications. This appointment reflects our group's ongoing commitment to high-impact, international scientific research at the Universidad Autónoma de Ciudad Juárez (UACJ).
📌 Call for Papers: Researchers are encouraged to submit their manuscripts. The submission deadline is January 03, 2027. 🔗 Learn more and submit your work here: Springer Nature Collection Link
February 19, 2026
The Nanomedicine Research Group at the Universidad Autónoma de Ciudad Juárez (UACJ) had the honor of hosting Dr. Luis Exequiel Ibarra, Adjunct Professor and Researcher at the Universidad Nacional de Río Cuarto (Argentina), as part of the Latin American Academic Exchange Program (PILA).
Dr. Ibarra conducted an extensive international search for leading research groups in medical nanotechnology before selecting our group at UACJ as the host institution for his research stay. His decision was based on the scientific output, ongoing translational research projects, and the interdisciplinary structure of our team.
Dr. Ibarra holds a PhD in Science and Technology and has developed his research career in nanomedicine and therapeutic compound design for cancer treatment, including research in Argentina, Spain, and Italy.
During his stay, he will:
Engage in collaborative research discussions with faculty from the Institute of Engineering and Technology (IIT) and the Institute of Biomedical Sciences.
Deliver seminars and workshops on nanomedicine and nanoparticle-based cancer therapies.
Explore joint research proposals and future institutional agreements.
This visit strengthens international collaboration between Universidad Autónoma de Ciudad Juárez and partner institutions in Latin America, reinforcing our commitment to high-impact translational nanomedicine research.
February 04, 2026
In the context of World Cancer Day, researchers from the Universidad Autónoma de Ciudad Juárez (UACJ) report a recent scientific publication addressing innovative approaches in cancer-related drug delivery. The study, published in the journal Polymers, presents the development of polymer-based microparticle systems designed for the co-release of a chemotherapeutic agent (cytarabine) and a polyphenol-rich extract derived from pecan nuts.
The research was carried out through a multidisciplinary collaboration involving the Laboratory of Nanomedicine (Institute of Engineering and Technology), the Department of Chemical and Biological Sciences, the Department of Physics and Mathematics, and the Department of Veterinary Sciences.
This work aligns with the objectives promoted by the First University Forum “UACJ vs Cancer: Learning to Prevent and Support”, reinforcing the University’s commitment to scientific research, student training, and the generation of knowledge aimed at addressing pressing public health challenges such as cancer.
🔗research paper: https://doi.org/10.3390/polym18030394
🔗forum: UACJ abre el diálogo contra el cáncer - COMUNICACIÓN UNIVERSITARIA
January 15, 2026
The Nanomedicine Research Group at the Universidad Autónoma de Ciudad Juárez (UACJ) highlights the successful development of a biomaterial-based skin patch created by Cintia América Pérez Vázquez, an undergraduate student in Nanotechnology Engineering from the Universidad Tecnológica de Ciudad Juárez (UTCJ), during her professional research stay in our laboratory.
The project focuses on the fabrication of electrospun hyaluronic acid nanofibrous membranes incorporated with ellagic acid, a bioactive polyphenol derived from pecan nut by-products. These highly porous structures enable controlled release of antioxidant and anti-inflammatory compounds, with potential applications in scar reduction, skin regeneration, drug delivery systems, tissue engineering, and diabetic foot treatment.
This work demonstrates the value of interinstitutional collaboration and early involvement of undergraduate students in applied nanomedicine research. The project has reached the in vitro release testing stage and has already received state-level recognition in the area of Materials Engineering and Science.
At UACJ, we remain committed to mentoring young talent and translating nanotechnology-based research into solutions with biomedical and social impact.
January 12, 2026
Dr. Christian Chapa González, head of the Nanomedicine Research Group at the Universidad Autónoma de Ciudad Juárez (UACJ), was invited as a plenary speaker at SAiNTS 2026, an international conference hosted by CHRIST (Deemed to be University) in Bengaluru, India. The conference brought together researchers from multiple disciplines to discuss scientific advances aligned with sustainability and emerging technologies.
During the plenary lecture, Dr. Chapa presented recent advances from a SECIHTI-funded research project focused on the development of bioactive compound-loaded polymeric nanostructures. The work addresses the design and fabrication of polymer-based nano- and microstructured systems capable of delivering antioxidant and anti-inflammatory compounds in a controlled manner.
These nanostructured platforms are being explored for biomedical applications such as skin regeneration, tissue engineering, and advanced drug delivery systems. The research integrates polymer science, nanotechnology, and bioactive compounds derived from natural sources, with an emphasis on functionality, biocompatibility, and translational potential.
Participation in SAiNTS 2026 contributed to the international visibility of research carried out at UACJ and enabled direct interaction with leading scientists in the fields of biomaterials and nanomedicine. The event also opened opportunities for future collaboration and publication, reinforcing the global presence of SECIHTI-supported research developed within the Nanomedicine Research Group.